# To Explore Cognitive Neural Mechanism of Autoimmune Encephalitis by Using Neuropsychological Tests and Multi-modal MRI

> **NCT03530462** · — · COMPLETED · sponsor: **First Affiliated Hospital of Zhejiang University** · enrollment: 22 (actual)

## Conditions studied

- Cognitive Impairment
- Autoimmune Encephalitis

## Interventions

- **DRUG:** rituximab
- **DRUG:** cyclophosphamide
- **DRUG:** Steroids
- **DRUG:** Intravenous immunoglobulin

## Key facts

- **NCT ID:** NCT03530462
- **Lead sponsor:** First Affiliated Hospital of Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-07
- **Primary completion:** 2018-02-28
- **Final completion:** 2018-02-28
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2018-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03530462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03530462, "To Explore Cognitive Neural Mechanism of Autoimmune Encephalitis by Using Neuropsychological Tests and Multi-modal MRI". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03530462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
